New Treatment for Prostate Cancer
January 01, 2014
Men with advanced prostate cancer have a new treatment option at Providence Saint Joseph Medical Center.
A new, FDA-approved drug called Xofigo has been shown to improve survival by targeting cancers that come back despite surgical or drug treatments to lower testosterone.
A study funded by Bayer HealthCare, the maker of Xofigo, suggests the drug extends life by three months on average, and it also may relieve pain in some patients.
The Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph is the first community cancer center in the San Fernando Valley to offer this innovative treatment option.
This treatment adds to Providence Saint Joseph’s impressive arsenal of advanced technologies in radiation and medical and surgical oncology. Along with complementary therapies, we offer a level of customized cancer treatment available in just a few of the country’s leading cancer centers.